• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高体重指数和低体重指数可能预示炎症性肠病患儿的病情严重。

High and low body mass index may predict severe disease course in children with inflammatory bowel disease.

作者信息

Yerushalmy-Feler Anat, Ben-Tov Amir, Weintraub Yael, Amir Achiya, Galai Tut, Moran-Lev Hadar, Cohen Shlomi

机构信息

a Pediatric Gastroenterology Unit , ' Dana-Dwek' Children's Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University , Tel Aviv , Israel.

出版信息

Scand J Gastroenterol. 2018 Jun;53(6):708-713. doi: 10.1080/00365521.2018.1464595. Epub 2018 Apr 24.

DOI:10.1080/00365521.2018.1464595
PMID:29688090
Abstract

OBJECTIVES

Inflammatory bowel disease (IBD) has been historically associated with underweight and malnutrition. The impact of both underweight and obesity on the clinical course of IBD in adults is controversial. This study described the association between body mass index (BMI) at diagnosis to disease course in children with IBD.

METHODS

We reviewed the medical records of children with IBD from the database of the 'Dana-Dwek' Children's Hospital between 2010 and 2016. Demographic and anthropometric data were collected as were disease characteristics, course and therapy. Patients were categorized in quartiles according to BMI percentiles at diagnosis (Q1-Q4).

RESULTS

Of 100 children who were identified, 62 had Crohn's disease (CD) and 38 had ulcerative colitis (UC). The median age (interquartile range, IQR) at diagnosis was 13.7 (range 11.9-15.2) years. The median (IQR) follow-up was 2.1 (1.2-3.8) years. At diagnosis, 46 children (46%) were in Q1, 20 (20%) in Q2, 19 (19%) in Q3 and 15 (15%) in Q4. Prolonged time to diagnosis was associated with BMI in Q1 and Q4, as well as high disease activity at diagnosis (p < .001). In a multivariate analysis, BMI in the lower and upper quartiles was associated with disease exacerbation (HR 3.212 and 4.651, respectively, p = .016) and anti-tumor necrosis factor (TNF) therapy (HR 4.489 and 3.972, respectively, p = .021).

CONCLUSIONS

BMI in the lower and upper quartiles was associated with more severe disease course in children with IBD. BMI may serve as a simple and highly accessible predictor of pediatric IBD course and prognosis.

摘要

目的

炎症性肠病(IBD)在历史上一直与体重不足和营养不良相关。体重不足和肥胖对成人IBD临床病程的影响存在争议。本研究描述了IBD患儿诊断时的体重指数(BMI)与疾病病程之间的关联。

方法

我们回顾了2010年至2016年间“达纳 - 德维克”儿童医院数据库中IBD患儿的病历。收集了人口统计学和人体测量数据以及疾病特征、病程和治疗情况。根据诊断时的BMI百分位数将患者分为四分位数(Q1 - Q4)。

结果

在确诊的100名儿童中,62例患有克罗恩病(CD),38例患有溃疡性结肠炎(UC)。诊断时的中位年龄(四分位间距,IQR)为13.7岁(范围11.9 - 15.2岁)。中位(IQR)随访时间为2.1年(1.2 - 3.8年)。诊断时,46名儿童(46%)处于Q1,20名(20%)处于Q2,19名(19%)处于Q3,15名(15%)处于Q4。诊断时间延长与Q1和Q4的BMI以及诊断时的高疾病活动度相关(p < 0.001)。在多变量分析中,较低和较高四分位数的BMI与疾病加重相关(风险比分别为3.212和4.651,p = 0.016)以及抗肿瘤坏死因子(TNF)治疗相关(风险比分别为4.489和3.972,p = 0.021)。

结论

较低和较高四分位数的BMI与IBD患儿更严重的疾病病程相关。BMI可作为小儿IBD病程和预后的简单且易于获取的预测指标。

相似文献

1
High and low body mass index may predict severe disease course in children with inflammatory bowel disease.高体重指数和低体重指数可能预示炎症性肠病患儿的病情严重。
Scand J Gastroenterol. 2018 Jun;53(6):708-713. doi: 10.1080/00365521.2018.1464595. Epub 2018 Apr 24.
2
BMI in the lower and upper quartiles at diagnosis and at 1-year follow-up is significantly associated with higher risk of disease exacerbation in pediatric inflammatory bowel disease.在诊断时和随访 1 年时,BMI 在较低和较高四分位与儿科炎症性肠病疾病恶化的风险显著相关。
Eur J Pediatr. 2021 Jan;180(1):21-29. doi: 10.1007/s00431-020-03697-2. Epub 2020 Jun 4.
3
Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.10岁及以下儿童炎症性肠病的临床病程及诊断结果:来自英国和意大利两个三级医疗中心的回顾性队列研究
BMC Gastroenterol. 2016 Mar 15;16:35. doi: 10.1186/s12876-016-0455-y.
4
Nutritional status of children with inflammatory bowel disease in Saudi Arabia.沙特阿拉伯炎症性肠病患儿的营养状况。
World J Gastroenterol. 2016 Feb 7;22(5):1854-8. doi: 10.3748/wjg.v22.i5.1854.
5
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.英夫利昔单抗和其他抗肿瘤坏死因子 α 治疗药物治疗炎症性肠病。
BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000.
6
Analysis and prediction of nutritional outcome of patients with pediatric inflammatory bowel disease from Bahrain.巴林小儿炎症性肠病患者营养结局的分析与预测
BMC Pediatr. 2024 Apr 24;24(1):265. doi: 10.1186/s12887-024-04720-3.
7
Impact of Obesity on Short- and Intermediate-Term Outcomes in Inflammatory Bowel Diseases: Pooled Analysis of Placebo Arms of Infliximab Clinical Trials.肥胖对炎症性肠病短期和中期结局的影响:英夫利昔单抗临床试验安慰剂臂的汇总分析。
Inflamm Bowel Dis. 2018 Sep 15;24(10):2278-2284. doi: 10.1093/ibd/izy135.
8
Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.接受抗肿瘤坏死因子α制剂治疗的炎症性肠病儿科患者中的银屑病和银屑病样皮疹
Pediatr Dermatol. 2017 May;34(3):253-260. doi: 10.1111/pde.13081. Epub 2017 Feb 17.
9
The natural history of pediatric-onset IBD-unclassified and prediction of Crohn's disease reclassification: a 27-year study.儿童期起病的未分类炎症性肠病的自然病史及克罗恩病重新分类的预测:一项为期27年的研究
Scand J Gastroenterol. 2017 May;52(5):558-563. doi: 10.1080/00365521.2017.1282008. Epub 2017 Jan 27.
10
Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents.停用肿瘤坏死因子α阻断剂后达到深度缓解的炎症性肠病患者的长期预后
Scand J Gastroenterol. 2017 Mar;52(3):284-290. doi: 10.1080/00365521.2016.1250942. Epub 2016 Nov 3.

引用本文的文献

1
Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions.炎症性肠病的饮食干预与口服营养补充:当前证据与未来方向
Nutrients. 2025 May 30;17(11):1879. doi: 10.3390/nu17111879.
2
C-reactive protein-to-albumin ratio and neutrophil-to-albumin ratio for predicting response and prognosis to infliximab in ulcerative colitis.C反应蛋白与白蛋白比值及中性粒细胞与白蛋白比值对预测溃疡性结肠炎患者英夫利昔单抗的反应和预后的价值
Front Med (Lausanne). 2024 Mar 12;11:1349070. doi: 10.3389/fmed.2024.1349070. eCollection 2024.
3
Association between body mass index and age of disease onset with clinical outcomes in paediatric-onset Crohn's Disease (CD): a UK nation-wide analyses using the NIHR-IBD BioResource.
英国国民健康保险制度-炎症性肠病生物资源全国范围内分析:利用该资源评估体质指数与发病年龄对儿科发病克罗恩病(CD)临床结局的影响。
Eur J Clin Nutr. 2024 Jun;78(6):534-540. doi: 10.1038/s41430-024-01425-9. Epub 2024 Mar 12.
4
Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study.与炎症性肠病相关的生活方式因素:来自瑞士 IBD 队列研究的数据。
BMC Gastroenterol. 2023 Mar 12;23(1):71. doi: 10.1186/s12876-023-02692-9.
5
Disease Activity Is Associated with Obesity in Newly Diagnosed Pediatric Patients with Ulcerative Colitis.疾病活动度与新诊断为溃疡性结肠炎的儿科患者的肥胖相关。
Int J Environ Res Public Health. 2022 Dec 1;19(23):16091. doi: 10.3390/ijerph192316091.
6
Nomogram to predict primary non-response to infliximab in patients with Crohn's disease: a multicenter study.预测克罗恩病患者对英夫利昔单抗原发性无反应的列线图:一项多中心研究
Gastroenterol Rep (Oxf). 2020 Nov 12;9(4):329-338. doi: 10.1093/gastro/goaa069. eCollection 2021 Aug.
7
Body Mass Index and Disease Activity Are Associated With Moderate to Severe Disability in Crohn's Disease: A Cross-Sectional Study in Shanghai.体重指数和疾病活动与克罗恩病的中度至重度残疾相关:一项在上海开展的横断面研究
Front Med (Lausanne). 2021 Jul 9;8:662488. doi: 10.3389/fmed.2021.662488. eCollection 2021.
8
Dietary Management in Pediatric Patients with Crohn's Disease.小儿克罗恩病的饮食管理。
Nutrients. 2021 May 11;13(5):1611. doi: 10.3390/nu13051611.
9
Role of Adipose Tissue in Inflammatory Bowel Disease.脂肪组织在炎症性肠病中的作用。
Int J Mol Sci. 2021 Apr 19;22(8):4226. doi: 10.3390/ijms22084226.
10
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study.炎症性肠病中肥胖的患病率及相关因素:一项病例对照研究。
World J Gastroenterol. 2020 Dec 21;26(47):7528-7537. doi: 10.3748/wjg.v26.i47.7528.